At a crossroads: how to translate the roles of PI3K in oncogenic and metabolic signalling into improvements in cancer therapy.

Vasan, Neil; Cantley, Lewis C

Vasan, Neil; Cantley, Lewis C.

Affiliation

Vasan N; Department of Medicine, Division of Hematology/Oncology, Columbia University Irving Medical Center, New York, NY, USA.
Cantley LC; Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY, USA.

Nat Rev Clin Oncol ; 19(7): 471-485, 2022 07.

Article in En | MEDLINE | ID: mdl-35484287

Subject(s)

Breast Neoplasms; Phosphatidylinositol 3-Kinase; Breast Neoplasms/drug therapy; Carcinogenesis; Female; Humans; Phosphatidylinositol 3-Kinase/metabolism; Phosphatidylinositol 3-Kinases/genetics; Phosphatidylinositol 3-Kinases/metabolism; Phosphoinositide-3 Kinase Inhibitors/therapeutic use; Proto-Oncogene Proteins c-akt

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Phosphatidylinositol 3-Kinase Limits: Female / Humans Language: En Journal: Nat Rev Clin Oncol Year: 2022 Document type: Article

Fulltext

XML

PubMed Links

Search on Google